|
|
|
Xtalks, online
2023 -2-02
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. The featured speakers believe these challenges can be overcome by leveraging real-world data and reusing existing data, so the benefits of digital medicine can finally be reaped. This webinar will cover:
What to look for in digital biomarkers What it takes to validate a digital biomarker Why real-world data are critical to this effort A case study showing how to reuse existing data to validate an open-source digital biomarker Key success factors to enable reuse of data Regulatory and clinical decision-making factors Patient privacy issues Attendees looking to develop and/or validate digital biomarkers will find this webinar very informative. Register today to learn more about creating digital biomarkers with real-world and existing data.
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
Invited Speakers:
|
|
Dr. Daniel R. Karlin, MD, MA, Chief Medical Officer, MindMed Dr. James Connolly, Lecturer in Computing at Atlantic Technical University, Co. Donegal, Ireland Dr. William Crown, Distinguished Scientist at Brandeis, The Heller School for Social Policy and Management (Moderator) Geoff Gill, President, Shimmer Research Inc.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -2-02
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|